Head Office
Protox Therapeutics Inc.
1210-885 West Georgia Street
Vancouver, BC Canada V6C 3E8
t: 604.688.0199
f: 604.688.0173
info@protoxtherapeutics.com

Map of Location

For Business Development inquiries, contact Tom D'orazio at:
business@protoxtherapeutics.com

For Investor inquiries, contact James Beesley at:
ir@protoxtherapeutics.com

For Clinical Trial inquiries, contact Nina Merchant at:
clinical@protoxtherapeutics.com

For all other inquiries,
info@protoxtherapeutics.com

What's New

June 2 2010
Protox Announces Positive Six Month Phase 2B BPH Results

June 1, 2010
Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

May 13, 2010
Protox Reports First Quarter 2010 Financial Results

April 29, 2010
Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

Stock Quote

	LAST TRADE:	$0.39
	TRADE TIME:	3:53PM EST
	CHANGE:	$0.00 (0.00%)
	PREV CLOSE:	$0.39
	OPEN:	$0.39
	BID:	$0.385
	ASK:	$0.39